Nystatine Rph

Nystatin, the active ingredient in Nystatin Rph, is a polyene antifungal presented as a dosage form for oral or topical use. It treats Candida infections of the mucous membranes, skin and gastrointestinal tract in children and adults.

GNH USA supplies Nystatin Rph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Nystatin is used to manage fungal infections caused by Candida species across several body sites.

- Oropharyngeal candidiasis: reduces yeast colonisation and relieves symptoms of oral thrush. - Esophageal candidiasis: helps clear fungal infection and improve swallowing. - Cutaneous candidiasis: treats skin infections such as diaper rash and intertrigo. - Gastrointestinal candidiasis: controls overgrowth of Candida in the GI tract. - Vaginal candidiasis: alleviates itching and discharge caused by yeast infection.

Nystatin may cause adverse reactions, most of which are mild and localized.

Common Side Effects: - Nausea: mild stomach upset after oral administration. - Vomiting: occasional emesis following dose. - Diarrhoea: loose stools may occur. - Abdominal pain: cramping or discomfort. - Skin irritation: redness or itching at the site of topical application. - Taste alteration: temporary change in taste perception.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hepatic dysfunction: rare liver enzyme elevations. - Neutropenia: uncommon reduction in white blood cells. - Stevens‑Johnson syndrome: extremely rare severe skin reaction. - Anaphylaxis: life‑threatening hypersensitivity (very rare).

Before using Nystatin, consider the following safety measures.

- Assess hypersensitivity: confirm no known allergy to polyene antifungals. - Monitor renal function: use caution in patients with impaired kidney function. - Observe for allergic reactions: discontinue if rash, swelling, or breathing difficulty occurs. - Use in immunocompromised patients: ensure close clinical supervision. - Limit duration: avoid prolonged use without medical review. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nystatin has limited systemic absorption, but certain co‑administered agents may affect its safety or efficacy.

Major Interactions (Avoid): - Concurrent systemic antifungals (e.g., amphotericin B): increased risk of additive toxicity. - Nephrotoxic drugs (e.g., aminoglycosides): may exacerbate renal side effects.

Moderate Interactions (Monitor Closely): - Antacids: may reduce absorption of oral suspension. - Broad‑spectrum antibiotics: can alter normal flora, affecting fungal balance. - Oral contraceptives: no clinically significant interaction, but monitor efficacy. - Probiotics: may diminish antifungal effect when taken simultaneously. - Other topical agents: assess for skin irritation when layered.